welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- login
Abstracts & Posters
P4.1 Puberty is delayed or absent in Duchenne Muscular Dystrophy boys on chronic glucocorticoid therapy
source: Neuromuscular Disorders
year: 2011
authors: M.M. Rutter, S.R. Rose, J. Collins, H. Sucherew, B.L. Wong, I. Rybalsky
summary/abstract:Chronic glucocorticoids (GCs) are standard therapy and slow disease progression in Duchenne Muscular Dystrophy (DMD). However, GCs cause adverse endocrine effects, including pubertal delay, growth failure and osteoporosis. Absent/delayed puberty is an important problem in DMD which, in turn, negatively impacts bone health, growth, self esteem and muscle strength. The prevalence in DMD is unknown, and it is frequently under-recognized and untreated.
The objective is to determine the prevalence of absent /delayed puberty in DMD boys on GC therapy.
organization: Cincinnati Children’s Hospital Medical Center, USADOI: 10.1016/j.nmd.2011.06.966
read more
rareRelated
-
Bone health in boys with Duchenne Muscular Dystrophy on long-term daily deflazacort therapyQuality of life in Duchenne Muscular Dys...
-
Neurodevelopmental Needs in Young Boys with Duchenne Muscular Dystrophy (DMD): Observations from the Cooperative Int...Introduction: Duchenne muscular dystroph...
-
Delayed Puberty in Duchenne Muscular Dystrophy: For ParentsThis information sheet is about delayed ...
-
Longitudinal Pulmonary Function Testing Outcome Measures in Duchenne Muscular Dystrophy: Long-term Natural History w...We describe changes in pulmonary functio...
-
Finding the Optimum Regimen for Duchenne Muscular DystrophyThe Finding the Optimum Regimen for Duch...
-
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular DystrophyWhile it has been known for many years t...
-
The PJ Nicholoff Steroid Protocol for Duchenne and Becker Muscular Dystrophy and Adrenal SuppressionDuchenne muscular dystrophy (DMD or Duch...